Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2022-10-26 09:49:43
Oslo, October 26, 2022 - Observe Medical ASA (OSE: OBSRV) ("Observe Medical"or
the "Company"), will release its third quarter 2022 results on Thursday, 3
November 2022. The presentation will be made available on NewsWeb and the
Company's website at 07:00 CET on the same day.
Rune Nystad, CEO, and Per Arne Nygård, CFO, will host a presentation and Q&A
session at 08:30 CEST on the day of results. The presentation will take place at
Haakon VIIs gate 2 and will be available via webcast at the following link:
https://channel.royalcast.com/landingpage/hegnarmedia/20221103_4/
After the live event, the presentation and recording will be made available
under the Investor Relations section on the Company's website,
https://observemedical.com/investor-relations/.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik
(Norway), Gothenburg (Sweden), Oulu (Finland), and Seattle (the US). In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.
Further information is available at www.observemedical.com.